Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.44 |
| ▸ | GRM4 | Q14833 | 4/20 | 0.43 |
| ▸ | GRM8 | O00222 | 3/20 | 0.43 |
| ▸ | GRM6 | O15303 | 3/20 | 0.43 |
| ▸ | SLC1A5 | Q15758 | 2/20 | 0.40 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.39 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21189163 | 1.00 | SLC7A5 (0.44) | SLC7A5GRM4GRM8GRM6SLC1A5 | |
| SCHEMBL57178 | 1.00 | SLC7A5 (0.44) | SLC7A5GRM4GRM8GRM6SLC1A5 | |
| SCHEMBL21189160 | 1.00 | SLC7A5 (0.44) | SLC7A5GRM4GRM8GRM6SLC1A5 | |
| SCHEMBL29503063 | 1.00 | SLC7A5 (0.44) | SLC7A5GRM4GRM8GRM6SLC1A5 | |
| SCHEMBL21189161 | 1.00 | SLC7A5 (0.44) | SLC7A5GRM4GRM8GRM6SLC1A5 | |
| SCHEMBL21189162 | 1.00 | SLC7A5 (0.44) | SLC7A5GRM4GRM8GRM6SLC1A5 | |
| SCHEMBL21189140 | 1.00 | SLC7A5 (0.44) | SLC7A5GRM4GRM8GRM6SLC1A5 | |
| SCHEMBL23739018 | 0.90 | GRM4 (0.44) | SLC7A5GRM4GRM8GRM6SLC1A5 | |
| SCHEMBL55395 | 0.89 | GRM8 (0.42) | GRM4GRM8GRM6SLC1A5BTN3A1 | |
| SCHEMBL21755921 | 0.88 | GRM4 (0.43) | SLC7A5GRM4GRM8GRM6SLC1A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10774098-B2 | Nahlsgen optical resolution method | KYOTO UNIVERSITY (JP) | 2020-09-15 | — | — | US | disclosed |
| US-20190225634-A1 | NAHLSGEN OPTICAL RESOLUTION METHOD | KYOTO UNIVERSITY (JP) | 2019-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10774098-B2 | Nahlsgen optical resolution method | HACL2, HAO2, HPD | SLC7A5 1949/4885GRM4 2303/4885GRM8 3303/4885 |
| US-20190225634-A1 | NAHLSGEN OPTICAL RESOLUTION METHOD | HACL2, HAO2, HPD | SLC7A5 1949/4885GRM4 2303/4885GRM8 3303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.